2/16/2021 - Studying the Elimination of Anti-Rejection Medications

from KidneyTalk - An Online Radio Show By Renal Support Network · host Lori Hartwell

Kidney transplant recipients deal with taking anti-rejection meds for life. Talaris is developing an alternative to immunosuppression. Nancy Krieger, MD, Talaris Therapeutics Chief Medical Officer, explains how this new treatment will work and how it differs from what is currently prescribed. She also talks about how you can learn more about the clinical trials that are available.

Episode metadata supplied by the publisher feed · Published Feb 16, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

2/16/2021 - Studying the Elimination of Anti-Rejection Medications

0:00 0:00

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

When was this KidneyTalk - An Online Radio Show By Renal Support Network episode published?

This episode was published on February 16, 2021.

Can I download this KidneyTalk - An Online Radio Show By Renal Support Network episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!